Mitsubishi Chemical Group Corporation (TYO:4188)
Japan
· Delayed Price · Currency is JPY | Market Cap | 1.15T |
| Revenue (ttm) | 3.96T |
| Net Income (ttm) | 114.23B |
| Shares Out | 1.36B |
| EPS (ttm) | 81.43 |
| PE Ratio | 61.63 |
| Forward PE | 14.15 |
| Dividend | 32.00 (3.73%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 4,184,300 |
| Average Volume | 5,424,505 |
| Open | 852.80 |
| Previous Close | 857.90 |
| Day's Range | 843.10 - 856.50 |
| 52-Week Range | 594.10 - 900.90 |
| Beta | 0.41 |
| RSI | 48.72 |
| Earnings Date | Feb 3, 2026 |
About Mitsubishi Chemical Group
Mitsubishi Chemical Group Corporation provides performance products, industrial materials, industrial gases, and others in Japan and internationally. It operates in five segments: Specialty Materials, MA & Derivatives, Basic Materials & Polymers, Pharma, and Industrial Gases. The company provides chemicals; film & sheet/molding/composite; information/electronics/ display/ battery; environment & living solutions; polymers/resins, high performance chemicals; carbon/carbon fibers & composite materials; inorganic products; and agriculture/food mate... [Read more]
Financial Performance
In 2024, Mitsubishi Chemical Group's revenue was 4.41 trillion, an increase of 0.46% compared to the previous year's 4.39 trillion. Earnings were 45.02 billion, a decrease of -62.36%.
Financial StatementsNews
Q2 2026 Mitsubishi Chemical Group Corp Earnings Presentation Transcript
Q2 2026 Mitsubishi Chemical Group Corp Earnings Presentation Transcript
Bain Capital to buy Mitsubishi Chemical’s pharma unit for $3.3B
Mitsubishi Chemical Looks to Sell Pharma Unit, Nikkei Reports
Japanese chemical producer Mitsubishi Chemical Group Corp. is looking to sell its pharmaceutical unit, Mitsubishi Tanabe Pharma Corp., Nikkei reported on Monday.